Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Dimopoulos

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Annals of Internal Medicine|February 15, 2021
Calling a CodeChristina Dimopoulos
Inflammatory Bowel Diseases|October 12, 2020
SARS-CoV-2 Infection and Dual-Biologic Therapy for Crohn's DiseaseChristina Dimopoulos, Badr Al-Bawardy
Translational Gastroenterology and Hepatology|February 12, 2026
LiverPRO: a new screening test for fibrosis in steatotic liver diseaseChristina Dimopoulos-Verma, Amir Gougol, Aparna Goel
ACG Case Reports Journal|February 4, 2025
Fistulizing and Stricturing Esophageal Crohn's Disease Requiring EsophagectomyChristina Dimopoulos-Verma, Ashley Ott, Aaron Yeoh, et al.
Inflammatory Bowel Diseases|November 9, 2020
The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter StudyGuilherme Piovezani Ramos, Christina Dimopoulos, Nicholas M McDonald, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 17, 2020
Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC ConsortiumMarc Fenster, Quazim A Alayo, Aava Khatiwada, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2020
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative ColitisParakkal Deepak, Quazim A Alayo, Aava Khatiwada, et al.
Leukemia|February 6, 2020
Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplantMina D Aziz, Jay Shah, Urvi Kapoor, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Annals of Internal Medicine|February 15, 2021
Calling a CodeChristina Dimopoulos
Inflammatory Bowel Diseases|October 12, 2020
SARS-CoV-2 Infection and Dual-Biologic Therapy for Crohn's DiseaseChristina Dimopoulos, Badr Al-Bawardy
Translational Gastroenterology and Hepatology|February 12, 2026
LiverPRO: a new screening test for fibrosis in steatotic liver diseaseChristina Dimopoulos-Verma, Amir Gougol, Aparna Goel
ACG Case Reports Journal|February 4, 2025
Fistulizing and Stricturing Esophageal Crohn's Disease Requiring EsophagectomyChristina Dimopoulos-Verma, Ashley Ott, Aaron Yeoh, et al.
Inflammatory Bowel Diseases|November 9, 2020
The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter StudyGuilherme Piovezani Ramos, Christina Dimopoulos, Nicholas M McDonald, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 17, 2020
Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC ConsortiumMarc Fenster, Quazim A Alayo, Aava Khatiwada, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2020
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative ColitisParakkal Deepak, Quazim A Alayo, Aava Khatiwada, et al.
Leukemia|February 6, 2020
Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplantMina D Aziz, Jay Shah, Urvi Kapoor, et al.
Pageof 1